247 related articles for article (PubMed ID: 30476585)
1. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
Younossi ZM; Stepanova M; Ong J; Yilmaz Y; Duseja A; Eguchi Y; El Kassas M; Castellanos-Fernandez M; George J; Jacobson IM; Bugianesi E; Wong VW; Arrese M; de Ledinghen V; Romero-Gomez M; Mendez-Sanchez N; Ahmed A; Wong R; Papatheodoridis G; Serfaty L; Younossi I; Nader F; Ziayee M; Afendy A;
Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1625-1633.e1. PubMed ID: 30476585
[TBL] [Abstract][Full Text] [Related]
2. Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.
VanWagner LB; Ning H; Allen NB; Ajmera V; Lewis CE; Carr JJ; Lloyd-Jones DM; Terrault NA; Siddique J
Gastroenterology; 2017 Nov; 153(5):1260-1272.e3. PubMed ID: 28802566
[TBL] [Abstract][Full Text] [Related]
3. The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease.
Zheng T; Wang X; Kamili K; Luo C; Hu Y; Wang D; Wang B; Gao P; Tian G
Scand J Gastroenterol; 2024 Apr; 59(4):480-488. PubMed ID: 38179969
[No Abstract] [Full Text] [Related]
4. Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease.
Hagström H; Hegmar H; Moreno C
United European Gastroenterol J; 2024 Mar; 12(2):168-176. PubMed ID: 38381115
[TBL] [Abstract][Full Text] [Related]
5. Metabolic dysfunction-associated fatty liver disease and heavy alcohol consumption increase mortality:A nationwide study.
Cho SH; Kim S; Oh R; Kim JY; Lee YB; Jin SM; Hur KY; Kim G; Kim JH
Hepatol Int; 2024 May; ():. PubMed ID: 38806774
[TBL] [Abstract][Full Text] [Related]
6. A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers.
Whitfield JB; Schwantes-An TH; Darlay R; Aithal GP; Atkinson SR; Bataller R; Botwin G; Chalasani NP; Cordell HJ; Daly AK; Day CP; Eyer F; Foroud T; Gleeson D; Goldman D; Haber PS; Jacquet JM; Liang T; Liangpunsakul S; Masson S; Mathurin P; Moirand R; McQuillin A; Moreno C; Morgan MY; Mueller S; Müllhaupt B; Nagy LE; Nahon P; Nalpas B; Naveau S; Perney P; Pirmohamed M; Seitz HK; Soyka M; Stickel F; Thompson A; Thursz MR; Trépo E; Morgan TR; Seth D;
J Hepatol; 2022 Feb; 76(2):275-282. PubMed ID: 34656649
[TBL] [Abstract][Full Text] [Related]
7. The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes.
Ma X; Zhu Y; Yeo YH; Fan Z; Xu X; Rui F; Ni W; Gu Q; Tong X; Yin S; Qi X; Shi J; Wu C; Li J
Hepatol Int; 2024 Jun; 18(3):952-963. PubMed ID: 38252365
[TBL] [Abstract][Full Text] [Related]
8. Alcoholic beverages and prostate cancer in a prospective US cohort study.
Watters JL; Park Y; Hollenbeck A; Schatzkin A; Albanes D
Am J Epidemiol; 2010 Oct; 172(7):773-80. PubMed ID: 20813803
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of alcohol-related cirrhosis in the next decade: estimates based on current epidemiological trends in the United States.
Guirguis J; Chhatwal J; Dasarathy J; Rivas J; McMichael D; Nagy LE; McCullough AJ; Dasarathy S
Alcohol Clin Exp Res; 2015 Nov; 39(11):2085-94. PubMed ID: 26500036
[TBL] [Abstract][Full Text] [Related]
10. Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans.
Kanwal F; Kramer JR; Duan Z; Yu X; White D; El-Serag HB
Clin Gastroenterol Hepatol; 2016 Feb; 14(2):301-8.e1-2. PubMed ID: 26291667
[TBL] [Abstract][Full Text] [Related]
11. Novel metabolic phenotypes for extrahepatic complication of nonalcoholic fatty liver disease.
Yi J; Wang L; Guo J; Ren X
Hepatol Commun; 2023 Jan; 7(1):e0016. PubMed ID: 36633488
[TBL] [Abstract][Full Text] [Related]
12. Changes in metabolic complications in patients with alcoholic fatty liver disease monitored over two decades: NAGALA study.
Hamaguchi M; Obora A; Okamura T; Hashimoto Y; Kojima T; Fukui M
BMJ Open Gastroenterol; 2020; 7(1):e000359. PubMed ID: 32337056
[TBL] [Abstract][Full Text] [Related]
13. New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice.
Canivet CM; Boursier J; Loomba R
Semin Liver Dis; 2024 Feb; 44(1):35-42. PubMed ID: 38531378
[TBL] [Abstract][Full Text] [Related]
14. Cadmium exposure and liver disease among US adults.
Hyder O; Chung M; Cosgrove D; Herman JM; Li Z; Firoozmand A; Gurakar A; Koteish A; Pawlik TM
J Gastrointest Surg; 2013 Jul; 17(7):1265-73. PubMed ID: 23636881
[TBL] [Abstract][Full Text] [Related]
15. Occult liver disease: A multinational perspective.
Vidal-Cevallos P; Flores-García N; Chávez-Tapia NC; Chalasani NP
Ann Hepatol; 2024; 29(3):101480. PubMed ID: 38354950
[TBL] [Abstract][Full Text] [Related]
16. Screening for Fibrosis Promotes Lifestyle Changes: A Prospective Cohort Study in 4796 Individuals.
Kjaergaard M; Lindvig KP; Thorhauge KH; Johansen S; Hansen JK; Andersen P; Hansen CD; Schnefeld HL; Bech KT; Torp N; Israelsen M; Detlefsen S; Graupera I; Gines P; Krag A; Thiele M
Clin Gastroenterol Hepatol; 2024 May; 22(5):1037-1047.e9. PubMed ID: 38154729
[TBL] [Abstract][Full Text] [Related]
17. How does alcohol use impact morbidity and mortality of liver cirrhosis? A systematic review and dose-response meta-analysis.
Llamosas-Falcón L; Probst C; Buckley C; Jiang H; Lasserre AM; Puka K; Tran A; Zhu Y; Rehm J
Hepatol Int; 2024 Feb; 18(1):216-224. PubMed ID: 37684424
[TBL] [Abstract][Full Text] [Related]
18. Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among US Veterans With Steatotic Liver Disease.
Wong RJ; Yang Z; Cheung R; Singal AK; Do A; Ahmed A; Yeoh A
Gastroenterology; 2024 Jun; 166(6):1156-1165.e4. PubMed ID: 38428619
[TBL] [Abstract][Full Text] [Related]
19. The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease.
Trembling PM; Apostolidou S; Gentry-Maharaj A; Parkes J; Ryan A; Tanwar S; Burnell M; Harris S; Menon U; Rosenberg WM
BMC Gastroenterol; 2020 Apr; 20(1):104. PubMed ID: 32293289
[TBL] [Abstract][Full Text] [Related]
20. Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?
Romero-Gómez M; Arab JP; Oliveira CP; Hernández M; Arrese M; Cortez-Pinto H; Bataller R
Semin Liver Dis; 2024 Feb; 44(1):69-78. PubMed ID: 38574752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
